Genital Reassignment Surgery (GRS)
Genital Reassignment Surgery (GRS), also referred to as Gender Confirmation Surgery (GCS), Sex Reassignment Surgery (SRS) or Male-to-Female (MTF), is a surgical procedure that changes a person’s genitalia to match that of their sexual identity. During this procedure, surgeons will transform the transgender person’s pelvic area to create a neo-vagina. This procedure is also known as vaginoplasty. Post-operative vaginal dilation therapy is an integral component of keeping a transgender woman’s neo-vagina functional.
Genital Reassignment Surgery (GRS) surgeons will advise their patients on the proper use and frequency of post-op dilation. As part of their physical transition, a transgender patient will typically begin using vaginal dilators a few days after surgery. Vaginal dilation therapy is almost always required for life, as sexual intercourse in place of dilation may not be sufficient.
Did you know?
- The number of gender reassignment procedures conducted in the United States each year is estimated at between 100 and 500
- 2-5% of the US population is transgender
- There are 143 US cities and counties that have jurisdictions with transgender explicit non-discrimination laws
- Most transsexuals seek treatment between the ages of 15 and 35
- Roughly 1 per 30,000 adult males and 1 per 100,000 adult females seek sex reassignment surgery